An Efficacy Trial of Mobile Technology for Reducing and Preventing Adolescent Suicide
- Institution
- OUI THERAPEUTICS, INC, CT
- Principal investigator
- Patricia Simon
- Funding
- $596K
- Duration
- 2021–2026
Moonbase score
Still being scored
Abstract
ABSTRACT Suicide is a leading cause of death in the US and suicide rates have steadily increased. Despite this, there is a paucity of interventions that reduce suicide ideation and behavior. In this project, we seek to enhance a beta version of our suicide prevention digital therapeutic (developed in phase I) and conduct a randomized controlled trial to evaluate the efficacy of the digital therapeutic for suicide-related outcomes. This project will contribute to our understanding of the use of mobile technology as a suicide prevention tool.
Research team
- Seth FeuersteinPI
- Patricia SimonPI
LOADING MOONBASE SCORE
Questions for Oui Therapeutics, Inc
Oui Therapeutics, Inc hasn't set up its Moonbase portfolio yet, so questions about this research can't be asked here.
Related grants
Same researchers, same topic, scored first.
- NIH · Oui Therapeutics, IncNot yet scored
Development and Evaluation of a Novel Digital Therapeutic for Adults with Post-Traumatic Stress Disorder
Seth Feuerstein · $417K · 2024–2026
- NIH · Brown UniversityNot yet scored
Harnessing culturally-appropriate, technology-assisted methods to advance suicide prevention among youth in Colombian school settings
Alethea Desrosiers · $55K · 2024–2027
- NIH · Brown UniversityNot yet scored
Harnessing culturally-appropriate, technology-assisted methods to advance suicide prevention among youth in Colombian school settings
Alethea Desrosiers · $138K · 2024–2027